Content on Cancer.Net is approved by the Cancer.Net Editorial Board, composed of nearly 200 medical, surgical, radiation, and pediatric oncologists, oncology nurses, physician assistants, social workers, and patient advocates.
The Cancer.Net Editors Meeting was held on October 11, 2022 and editors joined both virtually and in person. Editor in Chief Jyoti D. Patel, MD, FASCO, and the site’s Associate Editors reviewed additions and updates to Cancer.Net over the past year, set the 2023 goals for ASCO’s patient education program, and provided expert guidance to ensure that Cancer.Net’s content is comprehensive, credible, current, and accessible for people with cancer.
From top left is Charu Aggarwal, MD, MPH (Lung Cancer). Second row, from left, is Norah Lynn Henry, MD, PhD, FASCO (Breast Cancer), and Allison Magnuson, DO, MS (Geriatric Oncology). Third row, from left, is Daniel Mulrooney, MD, MS (Pediatric Cancers) and Fay Hlubocky, PhD, MA (Psychosocial Oncology). Fourth row, from left, is Jyoti Patel, MD, FASCO (Editor in Chief), and Vicki Keedy, MD, FASCO (Sarcoma). Fifth row is Richard Lee, MD (Palliative Care).
Not Pictured: Andrew Artz, MD, MS (Leukemia), Christopher Flowers, MD, (Lymphoma), Merry Jennifer Markham, MD, FACP, FASCO (Gynecologic Cancers), Glenn Lesser, MD, FACP (Central Nervous System Tumors), Sagar Lonial, MD, FACP (Myeloma), Sumanta Pal, MD, FASCO (Genitourinary (GU) Cancers), Manali Patel, MD, MPH, MS (Health Equity), Cristina Rodriguez, MD (Head and Neck Cancers), Katy Tsai, MD (Melanoma and Skin Cancers), and Matthew Yurgelun, MD, FASCO (Gastrointestinal (GI) Cancers).
View more information about Cancer.Net’s Associate Editors, who lead the Cancer.Net Editorial Board.
View more information about Cancer.Net’s Specialty Editors, who provide topic-specific expertise as part of the Cancer.Net Editorial Board.
View a listing of Cancer.Net’s full advisory panel, which reviews content as part of the Cancer.Net Editorial Board.